FDA
-
-
-
-
-
-
-
Palvella Therapeutics adds Matt Pauls to its board of directors
-
-
-
-
-
-
-
ResVita Bio Appoints John D. Doux, M.D., M.B.A., to Board of Directors
-
-
-
-
-
-
-
Palvella presents positive data for QTORIN rapamycin at vascular congress
-
-
-
-
-
-
-
Stephens Starts Palvella Therapeutics (PVLA) at Overweight
-
-
-
-
-
-
-
Palvella appoints dermatologist John Doux to board of directors
-
-
-
-
-
-
-
Palvella Therapeutics Announces Scientific Publication in Journal of Vascular Anomalies Highlighting the Infiltrative Growth and Therapeutic Challenges of Microcystic Lymphatic Malformations
-
-
-
-
-
-
-
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
-
328,151 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

